承担科研项目

1.高产荷斯坦奶牛核心种群高效繁育技术创新及应用.6700万.2020.09-2022.12.

2.高端奶牛种源挖掘及高效繁育关键技术创新.1800万。2022.02-2025.04

发表论文

1.Xueyun Bi,Pengbo Lou,Yongli Song,Zhengquan Yu.Msi1 promotes breast cancer metastasis by regulating invadopodia-mediated extracellular matrix degradation via the Timp3–Mmp9 pathway.Oncogene.2021.06.21.( IF:9.867,Q1)

2.Yongli Song1#, Zhongjian Chen2#, Yichen Tang#,Zhengquan Yu*,The Msi1-mTOR pathway drives the pathogenesis of Paget’s disease,Cell Research. 2020,0:1-19. (IF:20.507，Q1)

3. Yuhua Tian, Jiuzhi Xu, Li Yuan, Ran Zhao, Sujuan Du, Cong Lv, Ruiqi Liu, Xiaole Sheng, Yongli Song, Zhengquan Yu, MiR-31 is a critical epithelial modulator of inflammatory and regenerative signals in human and mouse colitis, Gastroenterology. 2019 156:2281–2296. (IF:19.233, Q1)

4. Guang Yang,Caiyun Wang,Yongli Song*,Guifang Cao*. Development and Application of a High-Resolution Melting Analysis with Unlabeled Probes for the Screening of Short-Tailed Sheep TBXT Heterozygotes.Animals.2022.03.21(IF:3.231, Q1)

5.Yu Zheng, Yongli Song, Qi Han, Wenjie Liu, Jiuzhi Xu, Zhengquan Yu*, Ran Zhang*, Ning Li*，Intestinal epithelial cell-specific IGF1 promotes the expansion of intestinal stem cells during epithelial regeneration and functions on the intestinal immune homeostasis.Am J Physiol Endocrinol Metab. 2018 Oct 1;315(4):E638-E649. (IF:4.125, Q1)

6.Jianyun Shi, Xianghui Ma, Yang Su, Yongli Song, Zhengquan Yu, MiR-31 Mediates Inflammatory Signaling to Promote Re-Epithelialization during Skin Wound Healing.J Invest Dermatol. 2018 138(10):2253-2263. doi: 10.1016/j.jid.2018.03.1521. (IF:6.29, Q1)

7.Xianghui Ma, Yuhua Tian, Yongli Song, Zhengquan Yu. Msi2 maintains quiescent state of hair follicle stem cells by directly repressing the Hh signaling pathway. J Invest Dermatol.. 2017 Doi:10.1016/j.jid.2017.01.012.(IF:6.29, Q1)

8.Yue Zhang, Fengyin Li, Yongli Song, Zhengquan Yu. Numb and Numbl act to determine mammary myoepithelial cell fate, maintain epithelial identity, and support lactogenesis.The FASEB Journal 2016.DOI: 10.1096/fj.201600387R. (IF:5.595, Q2)